These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16700519)

  • 1. Possible role of DP IV inhibitors in acne therapy.
    Thielitz A; Reinhold D; Vetter R; Lendeckel U; Kähne T; Bank U; Helmuth M; Neubert K; Faust J; Hartig R; Wrenger S; Zouboulis CC; Ansorge S; Gollnick H
    Adv Exp Med Biol; 2006; 575():163-7. PubMed ID: 16700519
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
    Thielitz A; Reinhold D; Vetter R; Bank U; Helmuth M; Hartig R; Wrenger S; Wiswedel I; Lendeckel U; Kähne T; Neubert K; Faust J; Zouboulis CC; Ansorge S; Gollnick H
    J Invest Dermatol; 2007 May; 127(5):1042-51. PubMed ID: 16778789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sebocyte-derived leptin the missing link between hyperseborrhea, ductal hypoxia, inflammation and comedogenesis in acne vulgaris?
    Melnik BC
    Exp Dermatol; 2016 Mar; 25(3):181-2. PubMed ID: 26660941
    [No Abstract]   [Full Text] [Related]  

  • 4. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
    Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).
    Hinke SA; Pederson RA; McIntosh CH
    Adv Exp Med Biol; 2006; 575():119-33. PubMed ID: 16700515
    [No Abstract]   [Full Text] [Related]  

  • 6. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
    Thielitz A; Ansorge S; Bank U; Tager M; Wrenger S; Gollnick H; Reinhold D
    Front Biosci; 2008 Jan; 13():2364-75. PubMed ID: 17981718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.
    Kitlinska J; Kuo L; Abe K; Pons J; Yu M; Li L; Tilan J; Toretsky J; Zukowska Z
    Adv Exp Med Biol; 2006; 575():223-9. PubMed ID: 16700526
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of CD26/DPP IV in preservation of early pulmonary graft function.
    Jung FJ; Cardell M; Yang L; De Meester I; Augustyns K; Hillinger S; Scharpe S; Weder W; Korom S
    Adv Exp Med Biol; 2006; 575():231-5. PubMed ID: 16700527
    [No Abstract]   [Full Text] [Related]  

  • 9. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne.
    Zouboulis CC; Schagen S; Alestas T
    Arch Dermatol Res; 2008 Sep; 300(8):397-413. PubMed ID: 18690467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA synthesis in cultured human keratinocytes and HaCaT keratinocytes is reduced by specific inhibition of dipeptidyl peptidase IV (CD26) enzymatic activity.
    Vetter R; Reinhold D; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Ansorge S; Gollnick H
    Adv Exp Med Biol; 2000; 477():167-71. PubMed ID: 10849744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
    Clarke SB; Nelson AM; George RE; Thiboutot DM
    Dermatol Clin; 2007 Apr; 25(2):137-46, v. PubMed ID: 17430751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.
    Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH
    J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
    Park J; Ajami K; Yu DM; Gorrell MD
    Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
    Li L; Demuth HU; Zukowska Z
    Adv Exp Med Biol; 2006; 575():135-40. PubMed ID: 16700516
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.
    Stöckel-Maschek A; Stiebitz B; Born I; Faust J; Mögelin W; Neubert K
    Adv Exp Med Biol; 2000; 477():117-23. PubMed ID: 10849737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiopathology of acne vulgaris: recent data, new understanding of the treatments.
    Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B
    Eur J Dermatol; 2004; 14(1):4-12. PubMed ID: 14965788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne.
    Chen W; Yang CC; Liao CY; Hung CL; Tsai SJ; Chen KF; Sheu HM; Zouboulis CC
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):846-52. PubMed ID: 16898909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
    Del Rosso JQ; Schmidt NF
    Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of refractory acne.
    Pochi PE
    Hosp Pract (Off Ed); 1985 Oct; 20(10A):73-5, 79, 82. PubMed ID: 2932455
    [No Abstract]   [Full Text] [Related]  

  • 20. Phosphorus-containing inhibitors of proteolytic enzymes.
    Stöckel-Maschek A; Stiebitz B; Senns B; Lindner N; Mögelin W; Neubert K
    Adv Exp Med Biol; 2006; 575():19-26. PubMed ID: 16700504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.